Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159 GBX | +2.45% | +6.43% | +12.29% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
05-03 | Wall Street rises thanks to good and bad economic news |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 722.2 | 620.1 | 655.3 | 424.2 | 585 | 656.9 | - | - |
Enterprise Value (EV) 1 | 849.9 | 653.7 | 715.4 | 424.2 | 689.9 | 752.5 | 718 | 684 |
P/E ratio | 23.6 x | -21.2 x | 98.4 x | 14.9 x | 22.1 x | 18.4 x | 15.3 x | 13.5 x |
Yield | 0.59% | - | - | - | 1.98% | 2.35% | 2.76% | 3.09% |
Capitalization / Revenue | 2.06 x | 2.7 x | 2.41 x | 1.1 x | 1.26 x | 1.28 x | 1.23 x | 1.18 x |
EV / Revenue | 2.42 x | 2.84 x | 2.64 x | 1.1 x | 1.48 x | 1.47 x | 1.34 x | 1.23 x |
EV / EBITDA | 7.14 x | 10 x | 10.5 x | 4.04 x | 5.25 x | 5 x | 4.39 x | 3.93 x |
EV / FCF | 21.7 x | 40.9 x | -33.4 x | - | 24.3 x | 28.2 x | 14.4 x | 11.9 x |
FCF Yield | 4.6% | 2.45% | -2.99% | - | 4.12% | 3.55% | 6.94% | 8.41% |
Price to Book | 3.49 x | 2.26 x | 2.41 x | - | 2.1 x | 2.2 x | 2.03 x | 1.87 x |
Nbr of stocks (in thousands) | 368,458 | 442,916 | 443,961 | 437,748 | 413,120 | 413,120 | - | - |
Reference price 2 | 1.960 | 1.400 | 1.476 | 0.9690 | 1.416 | 1.590 | 1.590 | 1.590 |
Announcement Date | 20-03-02 | 21-03-19 | 22-03-08 | 23-03-07 | 24-03-05 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 350.6 | 229.8 | 271.4 | 385.7 | 465.3 | 513.5 | 535 | 557.1 |
EBITDA 1 | 119 | 65.3 | 67.9 | 104.9 | 131.5 | 150.6 | 163.6 | 174 |
EBIT 1 | 52.8 | -12.1 | 12.7 | 41.2 | 50.5 | 58.22 | 67.02 | 73.75 |
Operating Margin | 15.06% | -5.27% | 4.68% | 10.68% | 10.85% | 11.34% | 12.53% | 13.24% |
Earnings before Tax (EBT) 1 | 38.1 | -32.3 | 5.1 | 30.3 | 37.6 | 47.43 | 57.53 | 65.4 |
Net income 1 | 30.9 | -27.1 | 6.6 | 29 | 27.3 | 36.23 | 43.98 | 49.63 |
Net margin | 8.81% | -11.79% | 2.43% | 7.52% | 5.87% | 7.05% | 8.22% | 8.91% |
EPS 2 | 0.0830 | -0.0660 | 0.0150 | 0.0650 | 0.0640 | 0.0864 | 0.1038 | 0.1180 |
Free Cash Flow 1 | 39.1 | 16 | -21.4 | - | 28.4 | 26.72 | 49.84 | 57.5 |
FCF margin | 11.15% | 6.96% | -7.89% | - | 6.1% | 5.2% | 9.32% | 10.32% |
FCF Conversion (EBITDA) | 32.86% | 24.5% | - | - | 21.6% | 17.75% | 30.46% | 33.04% |
FCF Conversion (Net income) | 126.54% | - | - | - | 104.03% | 73.76% | 113.32% | 115.86% |
Dividend per Share 2 | 0.0115 | - | - | - | 0.0280 | 0.0373 | 0.0438 | 0.0492 |
Announcement Date | 20-03-02 | 21-03-19 | 22-03-08 | 23-03-07 | 24-03-05 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2023 S1 | 2023 S2 |
---|---|---|---|---|---|---|
Net sales 1 | - | 115 | - | 171.8 | - | 250.3 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | - | - | - | 22.3 | - | 31.5 |
Operating Margin | - | - | - | 12.98% | - | 12.58% |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income | -16.1 | - | - | - | 10 | - |
Net margin | - | - | - | - | - | - |
EPS | -0.0420 | - | -0.0250 | - | 0.0230 | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 20-09-02 | 21-03-19 | 21-09-01 | 22-03-08 | 23-09-05 | 24-03-05 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 128 | 33.6 | 60.1 | - | 105 | 95.6 | 61.1 | 27.1 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.073 x | 0.5145 x | 0.8851 x | - | 0.7977 x | 0.635 x | 0.3735 x | 0.1558 x |
Free Cash Flow 1 | 39.1 | 16 | -21.4 | - | 28.4 | 26.7 | 49.8 | 57.5 |
ROE (net income / shareholders' equity) | 19.7% | -5.96% | 3.76% | - | 11.7% | 12.9% | 14.3% | 15% |
ROA (Net income/ Total Assets) | - | - | - | - | - | 5.85% | 6.88% | 7.51% |
Assets 1 | - | - | - | - | - | 619.7 | 638.9 | 660.6 |
Book Value Per Share 2 | 0.5600 | 0.6200 | 0.6100 | - | 0.6700 | 0.7200 | 0.7800 | 0.8500 |
Cash Flow per Share 2 | 0.2900 | 0.1600 | 0.1000 | - | 0.2900 | 0.3200 | 0.3300 | 0.3500 |
Capex 1 | 65.6 | 48.5 | 66 | - | 93 | 110 | 96.6 | 99.2 |
Capex / Sales | 18.71% | 21.11% | 24.32% | - | 19.99% | 21.35% | 18.05% | 17.81% |
Announcement Date | 20-03-02 | 21-03-19 | 22-03-08 | 23-03-07 | 24-03-05 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.29% | 822M | |
0.00% | 1.76B | |
-29.81% | 356M | |
-20.73% | 217M | |
-28.78% | 194M | |
+2.47% | 176M | |
+121.49% | 124M | |
+50.34% | 133M | |
+29.52% | 107M |
- Stock Market
- Equities
- JSG Stock
- Financials Johnson Service Group PLC